KAYLA NORDSTROM: Open Payments
NPI 1285199844 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,610 in 93 payments from 13 companies in 2025. Trend: 2023 $2,001 · 2024 $2,186 · 2025 $1,610
Food & beverage: $1,599Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $463 |
| Janssen Biotech, Inc. | 14 | $289 |
| Ardelyx, Inc. | 6 | $189 |
| Gilead Sciences, Inc. | 7 | $161 |
| Intercept Pharmaceuticals, Inc. | 6 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $92 |
| QOL Medical, LLC | 4 | $75 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $73 |
| Phathom Pharmaceuticals, Inc. | 6 | $50 |
| PFIZER INC. | 2 | $42 |
Products named: TREMFYA, CREON, IBSRELA, RINVOQ, OCALIVA, SKYRIZI, ENTYVIO, Sucraid.
Industry payments across LA — which companies pay providers there.
